We have advised an IVD manufacturer on a bringing companion diagnostic to market with respect to a patient support program.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors (2)
Expertises
16 results
Newest first
We have assisted a diagnostics company with its companion diagnostics strategy, including the regulatory implications of combining diagnostic and therapeutic products.
We have advised a laboratory on the regulatory status of laboratory developed tests (LDTs) under the IVDR.
Axon advised a Dutch joint venture, that is active within the agri-food and agricultural biotechnology sector, on the transfer of its assets to a German investment fund. The transferred assets involved patent rights, plant breeders’ rights, trade secrets and biological materials.
Axon assisted a Dutch IVD company in securing a EUR 24M equity financing round, advising on the transaction structure, investment documentation and related matters.
Axon acted on behalf of an investor in connection with their investment in a clinical-stage biotech company developing first-in-class therapeutics and diagnostics for fibrosis. We conducted legal due diligence on the target company and reviewed the transaction documentation on behalf of the investors.